Sustainability Report

Overview

The report is Mayne Pharma's first sustainability report, covering the global Group's 2016 economic, environmental and social impacts. It reports AUD434.9 million revenue, 763 employees, total Scope 1 and 2 energy consumption of 139,433 GJ and total GHG emissions of 16,900 tCO2e. The report also describes its first materiality review and states that no external assurance was obtained.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2016
Period: 1 January 2016 – 31 December 2016
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services